What is Jakafi used for?
Information reviewed July 24, 2026
Jakafi (ruxolitinib) is a prescription medication used to treat Myelofibrosis and polycythemia vera. An oral treatment for certain bone-marrow cancers including myelofibrosis and polycythemia vera, as well as graft-versus-host disease.
More about Jakafi
More questions about Jakafi
Reference only
This information is for general reference and is not medical advice. Always consult a licensed healthcare professional about your treatment.